Measuring the success of bioDAOs through open onchain data is a key benefit of decentralized science, offering an alternative approach to traditional biotech, where data is often kept behind closed doors.
It’s also a critical component in the distribution of Bio/Acc Rewards, a new programmable incentive layer for the BIO network.
As we near our next cohort of bioDAOs, check out some top takeaways from our first onchain data analysis.
These highlights will give you insight into the current value of the BIO network, which is determined by the value of the underlying bioDAOs in our ecosystem and the scientific IP they back.
You’ll also get a sense of how holding the BIO token puts you on the pulse of DeSci’s fastest-growing network.
VitaDAO’s success shows that longevity starts with being early
VitaDAO has set an example of what early success in decentralized science looks like.
The longevity-focused bioDAO is currently leading the charge in onchain IP with key relationships across academia, including funding longevity research at University of Newcastle (through the work of the Viktor Korolchuk laboratory), the University of Copenhagen, and the University of Rochester.
New launches, research progress, and ways to get involved across the Biosphere.
This scientific R&D has come to life across a growing portfolio of tokenized assets created by VitaDAO and its community, resulting in $5,500,000 verified to onchain science thus far:
IP-NFTs: 8
IPTs: 2
Total IPT Market Capitalization: $7,500,000.00
Scientific applications: 1,400
$VITA, VitaDAO’s network token, currently sits at the top of the BIO network portfolio:
On the investor front, VitaDAO became the first bioDAO to receive funding from a traditional pharmaceutical sector through a $4.1M round, which included Pfizer Ventures. The funding round also included DeSci advocate and former Coinbase CTO Balaji Srinivasan, L1D.digital, Libertus Capital, Shine Capital, Collab Currency, and ZeePrime.
VitaDAO is also leading in bioDAO overall community size:
Discord Members: 10,721
Token holders (excluding layer 2s): 3,657
Genesis holders: 369
Holder growth MoM: 6.40%
X followers: 37,000
Join the VitaDAO community here, learn more about $VITA, and track its onchain activity on Etherscan.
CerebrumDAO show signs of steady growth across $NEURON & academic adoption
CerebrumDAO, a bioDAO focused on accelerating neuroscience, is growing fast only four months since its launch.
CerebrumDAO’s network token, $NEURON, has raised $1,145,347 in OTC activity, with a total raised of $2,143,347 in funding.
Select investors include Boost VC, Probiotic Ventures, and SpaceshipDAO.
Scientific AUM is also strong ($2,143,347), as are CerebrumDAO’s total contributions to onchain science ($250,000).
Check out CerebrumDAO’s financials snapshot below:
30-day market cap: $3,987,425
Total $ Raised in Genesis: $1,145,347
Multiple since Genesis 1.274
Total raised: $2,143,347
Cash in multisig: $1,700,000
With 85 scientific applications submitted and key relationships at Berkeley, Fission Pharma, ImmuneAGE Bio, Mass General Hospital’s Tanzi Lab, and the University of Texas, we recommend you keep this health-focused bioDAO top of mind.
Join the CerebrumDAO community here, learn more about $NEURON, and track its onchain activity on Etherscan.
HairDAO grows $HAIR’s market capitalization alongside consumer product line
From science-backed commercial products to the success of its governance token, HairDAO is targeting urgent issues while growing the value of its community — and the numbers don’t lie.
With the second-highest market capitalization in the BIO network portfolio ($28,595,217), over $39M in its multisig, $3,500,000 raised in OTC sales, and 20x in $HAIR since its genesis, HairDAO shows some of the most impressive signs of growth in the BIO network.
Other HairDAO accolades include investments from Libertus Capital, ZeePrime, Cherry VC, and DeSci-driving R&D at the University of Miami. One to watch.
Join the HairDAO community here, learn more about $HAIR, and its onchain activity on Etherscan. Want to experience the onchain success of our growing network of bioDAOs? Find out more here.
